GetTopicDetailResponse(id=3fdb5823386, topicName=新型抗癲癇藥, introduction=新型抗癲癇藥, content=null, image=null, comments=5, allHits=1143, url=https://h5.medsci.cn/topic?id=58233, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=76878, tagList=[TagDto(tagId=76878, tagName=新型抗癲癇藥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2039825, encodeId=ee68203982585, content=<a href='/topic/show?id=3fdb5823386' target=_blank style='color:#2F92EE;'>#新型抗癲癇藥#</a>, objectTitle=JAMA Neurology ： 新型抗癲癇藥物，是否增加患者自殺風(fēng)險？, objectType=article, longId=216505, objectId=1766216505d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1766216505d6, replyNumber=0, likeNumber=126, createdTime=2022-03-16, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1766216505d6, moduleTitle=JAMA Neurology ： 新型抗癲癇藥物，是否增加患者自殺風(fēng)險？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1766216505d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039824, encodeId=d72f203982495, content=<a href='/topic/show?id=3fdb5823386' target=_blank style='color:#2F92EE;'>#新型抗癲癇藥#</a>, objectTitle=2018 AAN/AES實踐指南：新型抗癲癇藥的療效和耐受性——**部分：新發(fā)癲癇的治療, objectType=article, longId=141830, objectId=a8bb141830d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8bb141830d8, replyNumber=0, likeNumber=76, createdTime=2018-09-11, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8bb141830d8, moduleTitle=2018 AAN/AES實踐指南：新型抗癲癇藥的療效和耐受性——**部分：新發(fā)癲癇的治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a8bb141830d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039823, encodeId=fe462039823f5, content=<a href='/topic/show?id=3fdb5823386' target=_blank style='color:#2F92EE;'>#新型抗癲癇藥#</a>, objectTitle=2018 AAN/AES實踐指南：新型抗癲癇藥的療效和耐受性——第二部分：治性癲癇的治療, objectType=article, longId=141829, objectId=bd8a14182942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd8a14182942, replyNumber=0, likeNumber=95, createdTime=2018-08-26, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd8a14182942, moduleTitle=2018 AAN/AES實踐指南：新型抗癲癇藥的療效和耐受性——第二部分：治性癲癇的治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bd8a14182942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039822, encodeId=284f2039822d5, content=<a href='/topic/show?id=3fdb5823386' target=_blank style='color:#2F92EE;'>#新型抗癲癇藥#</a>, objectTitle=Neurology：新型抗癲癇藥物治療指南I, objectType=article, longId=140858, objectId=82291408588f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82291408588f, replyNumber=0, likeNumber=123, createdTime=2019-06-01, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82291408588f, moduleTitle=Neurology：新型抗癲癇藥物治療指南I, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=82291408588f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039821, encodeId=3f1120398212e, content=<a href='/topic/show?id=3fdb5823386' target=_blank style='color:#2F92EE;'>#新型抗癲癇藥#</a>, objectTitle=新型抗癲癇藥物SAGE-547，臨床試驗初步見效, objectType=article, longId=42612, objectId=aafa42612de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aafa42612de, replyNumber=0, likeNumber=93, createdTime=2015-04-12, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aafa42612de, moduleTitle=新型抗癲癇藥物SAGE-547，臨床試驗初步見效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=aafa42612de)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
